MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in early diagnosis, personalized treatment, and family planning for Noonan Syndrome 10, improving patient outcomes and quality of life.
Explore genetic testing's impact on diagnosing and managing Noonan syndrome 9, highlighting early diagnosis, personalized treatment, and family planning benefits.
Unlock the potential of genetic testing for precise diagnosis and personalized management of Oculocutaneous Albinism Type 6, enhancing quality of life.
Explore how genetic testing sheds light on Optic Atrophy 9, offering early diagnosis, personalized treatments, and insights for family planning and research.
Explore Osteogenesis Imperfecta Type 17. Learn how genetic testing aids in accurate diagnosis, personalized treatment, family planning, and advancing research.
Explore how genetic testing enhances diagnosis and treatment of Parkinson Disease 21, revealing genetic markers, personalized therapies, and predictive family insights.
Unlock early detection of Parkinson Disease 22 with genetic testing. Identify LRRK2 mutations to personalize treatment and make informed family planning decisions.
Explore how genetic testing identifies the CAST gene variant in PLACK syndrome, aiding diagnosis, family planning, and research for targeted treatments.